This mechanism positions RNA-edited AZIN1 as a critical angiogenic driver in CRC, highlighting the translational potential of IL-8 antagonists (e.g., reparixin) in hyper-edited tumors (91). The gene discussed is CXCL8; the disease is colorectal carcinoma.